tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Indoco Remedies Receives GST Notice for Potential Tax Liability

Story Highlights
Indoco Remedies Receives GST Notice for Potential Tax Liability

Elevate Your Investing Strategy:

An announcement from Indoco Remedies Limited ( (IN:INDOCO) ) is now available.

Indoco Remedies Limited has received a notice from the GST Authority regarding a potential demand of Rs. 849.80 Lakhs for GST liabilities related to the period from 2021-2022. While the company plans to respond appropriately and does not anticipate this demand to materialize as a financial liability, it will keep stakeholders informed of any significant developments.

More about Indoco Remedies Limited

Indoco Remedies Limited is a pharmaceutical company involved in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company operates in the healthcare industry, focusing on domestic and international markets with a diverse range of therapeutic segments.

YTD Price Performance: -20.02%

Average Trading Volume: 7,238

Current Market Cap: 25.95B INR

Find detailed analytics on INDOCO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1